Earnings roundup: DuPont, Biogen Idec

Recs

0

Panic 2008... Profit 2009!

Fool -- Now's the time to invest! David and Tom Gardner's new book reveals their strategy for million dollar wealth.

Among the earnings stories for Tuesday, July 22, from AP Financial News:

Top stories:

Chemicals maker DuPont Co. said Tuesday agriculture sales and emerging markets helped fuel a rise in second-quarter profit, which was also boosted in part by a lawsuit settlement and a lower tax rate.

Other stories:

CAMBRIDGE, Mass. (AP) _ A surge in multiple-sclerosis drug sales drove an 11 percent boost in Biogen Idec Inc.'s second-quarter profit, prompting the biotechnology company to boost its full-year outlook and aim for record revenue of $4 billion.

ST. LOUIS (AP) _ Centene Corp. on Tuesday reported higher-than-expected second-quarter earnings, citing increased patient enrollment in its managed care plans.

HOUSTON (AP) _ BJ Services Co., an oilfield services company, said Tuesday its fiscal third-quarter profit fell 16 percent as lower prices at its U.S. pressure pumping operations cut into margins.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 689707, ~/articles/articlehandler.aspx, 1/8/2009 2:13:38 AM

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Jan 7 at 4:08 PM

Market Summary

DJIA 8,769.70 -245.40 -2.72%
S&P 500 906.65 -28.05 -3.00%
NASD 1,599.06 -53.32 -3.23%
Sponsored by:

Related Tickers

Biogen Idec, Inc.

CAPS Rating 4/5 Stars

$46.81

+0.34 (+0.73%)

Outperform564

Underperform44

Rate This Stock